Clinical Trial Update: Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms [NA]

View source ↗

Summary

A Canadian clinical trial evaluating MicroVention's Flow Re-Direction Endoluminal Device (FRED) stent system for intracranial aneurysms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Flow Re-Direction Endoluminal Device (FRED) Endoluminal Device Stent System (Flow Re-Direction Endoluminal Device (FRED) Stent System)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Intracranial Aneurysms | NA | Status: WITHDRAWN